The U.S. Department of Health and Human Services will post consumer warnings on flu.gov about wide price variations found by USA TODAY for a scarce liquid form of the H1N1 drug Tamiflu. U.S. Sen. Chris Dodd and U.S. Rep. Henry Waxman are calling for investigations of potential price gouging. HHS to warn consumers of flu drug price gouging
Faced with a shortage of a liquid form of the H1N1 drug Tamiflu, some pharmacies are making their own and charging prices that vary widely, a USA TODAY survey has found. At least two states' attorneys general are investigating. Prices for H1N1 drug Tamiflu vary widely for same dose
Pharmacies are scrambling to make their own version of liquid Tamiflu because of shortages of the manufacturer-made product. Experts are cautioning doctors to write prescriptions carefully to avoid dosing errors. Demand up for liquid Tamiflu
Alison Young
Alison Young has more than 20 years of experience as an investigative reporter and editor at major U.S. newspapers. She is currently a member of USA TODAY's investigative team and is past president of Investigative Reporters and Editors, a national journalism training organization. Young is a frequent speaker on the techniques of watchdog journalism. This site is her personal portfolio of articles and reporting tips. You can reach her at alisonyoungreports@hotmail.com or ayoung@usatoday.com.